curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

The Feasibility and Acceptability of a Collaborative Deprescribing Intervention to Reduce Anticholinergic Burden Among Hospitalised Older Patients

by palligoelme@gmail.com | May 20, 2026 | Clinical Trials

​ Conditions: Eligible Patients Are Aged 65 Years or More Admitted to One of the Five Medicines for Older People Wards, Who Have ACB Score of 3 or More Interventions: Other: Patients will receive a collaborative deprescribing intervention Sponsors: University of...

MEVA Cognitive Wellness Platform Study for Adults

by palligoelme@gmail.com | May 20, 2026 | Clinical Trials

​ Conditions: Cognitive Wellness; Healthy Aging; Age-Related Cognitive Change; Aging; Cognitive Change; Health Behavior; Primary Care Interventions: Behavioral: MEVA Cognitive Wellness Platform Sponsors: Mentage LLC Not yet recruiting Conditions: Cognitive Wellness;...

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

by palligoelme@gmail.com | May 20, 2026 | Clinical Trials

​ Conditions: Diabetic Retinopathy Interventions: Drug: Surabgene Lomparvovec; Drug: Sham; Drug: Topical Steroid; Drug: Artificial Tears Sponsors: AbbVie Recruiting Conditions: Diabetic Retinopathy Interventions: Drug: Surabgene Lomparvovec; Drug: Sham; Drug: Topical...

Effect of Diosmin/Hesperidin Combination on Platinum Compounds-Induced Nephropathy in Cancer Patients

by palligoelme@gmail.com | May 20, 2026 | Clinical Trials

​ Conditions: Cancer Patients Interventions: Combination Product: diosmin/hesperdin Sponsors: Beni-Suef University Recruiting Conditions: Cancer Patients Interventions: Combination Product: diosmin/hesperdin Sponsors: Beni-Suef University...

Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccination

by palligoelme@gmail.com | May 20, 2026 | Clinical Trials

​ Conditions: Pneumococcal Vaccines Interventions: Biological: 31-valent pneumococcal conjugate vaccine; Biological: PCV20 Sponsors: Vaxcyte, Inc. Recruiting Conditions: Pneumococcal Vaccines Interventions: Biological: 31-valent pneumococcal conjugate vaccine;...

Parasternal and Adductor Canal Blocks in CABG

by palligoelme@gmail.com | May 20, 2026 | Clinical Trials

​ Conditions: Postoperative Pain; Regional Anaesthsia; Pain Management Interventions: Procedure: parasternal block; Procedure: Parasternal block + Adductor canal block; Other: conventional analgesic regimen Sponsors: Zonguldak Bulent Ecevit University Not yet...
« Older Entries
Next Entries »

Recent Posts

  • A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.
  • Determination 2 – Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
  • Feasibility of a Community-Based Multimodal Exercise Programme in Parkinson’s Disease
  • cRCT of AI Agent in Clinital Resoning Training
  • Imaging CRF X NOP Interactions in Alcohol Use Disorder

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®